SVRA
SVRA
NASDAQ · Biotechnology

Savara Inc

$5.50
+0.12 (+2.23%)
As of Jun 21, 10:10 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +1,044.4% upside
Low Target $52.50
Average Target $62.94
High Target $80.97
Current Price $5.50
Current
$5.50
Target
$62.94
$52.50 $62.94 avg $80.97
Scenario Analysis
Bear Case
$52.50
854.5%
Low target
Base Case
$62.94
+1,044.4%
Avg target
Bull Case
$80.97
+1,372.2%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$7.01
-21.5% from high
52-Week Low
$1.98
+177.8% from low
Target vs 52W High
$62.94
+798.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -39.1%